About Dieter Weinand
Dieter Weinand is a chairman of the board at FORE US Bio.
Dieter Weinand first appears on SEC filings in 2023.
Experience
This experience comes from Dieter Weinand's profile and from SEC filings. For roles taken from filings, the years are when the filings name Dieter Weinand in the role, so the role may have started earlier or lasted longer.
UB
Umoja Biopharma Current
Chairman of the Board
2021 – Present
MT
Mnemo Therapeutics Current
Chairman of the Board
2021 – Present
FORE US Bio Inc. Current
Chairman of the Board
2020 – Present · Philadelphia, PA
Develops targeted cancer drugs for patients whose tumors have specific genetic changes.
RE
Replimune Current
Chairman of the Board of Directors
2016 – Present
BA
Bayer
President & CEO Bayer Pharma AG
1987 – 2018
PF
Pfizer
President, Primary Care Canada/Asia-Pac, (2012 – 2014)
President, Asia-Pacific Region (2010 – 2014)
2010 – 2014
BS
Bristol Myers Squibb
President, Intercontinental Division
2000 – 2010
WL
Warner-Lambert
Director/GM, Benelux
1999 – 2000
LE
Lederle
Product Manager
1990 – 1994
Key Colleagues at Startups
The people Dieter Weinand works with at each company, as listed on that company's latest Form D.
FORE US Bio Inc. · Form D/A, Jul 14, 2026
William Hinshaw
Executive officer and director
Michael Byrnes
Chief Financial Officer
Giovanni Mariggi
Co-founder and Partner at Medicxi, director
Kim Blackwell
Director
Erez Chimovits
Senior Managing Director at Orbimed
RD
Rajeev Dadoo
COO and Managing Partner of SR One, director
Chandra Leo
Partner at HBM Partners and director